Veterinary Medicines

OVAX MGS, ενέσιμο εναιώρημα για πρόβατα

Authorised
  • Staphylococcus aureus, Inactivated
  • Staphylococcus aureus, Inactivated
  • Staphylococcus aureus inactivated bacteria
Download as PDF

Product identification

Medicine name:
OVAX MGS, ενέσιμο εναιώρημα για πρόβατα
Active substance:
  • Staphylococcus aureus, Inactivated
  • Staphylococcus aureus, Inactivated
  • Staphylococcus aureus inactivated bacteria
Target species:
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Staphylococcus aureus, Inactivated
    2000.00
    antigen unit(s)
    /
    1.00
    Dose
  • Staphylococcus aureus, Inactivated
    120.00
    antigen unit(s)
    /
    1.00
    Dose
  • Staphylococcus aureus inactivated bacteria
    16.00
    billion colony forming units
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 12473/10-04-1997/K-0092201
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."